Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity

US Patent 11963949 · Granted Apr 23, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for selective binding to estrogen receptors alpha/beta relative to GPE2025
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2021
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2021
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2021
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2021
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2020
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2020
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2020
Inhibition and treatment of bacterial infections by sex-specific GPER targeting2020
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2019
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2019
Method for treating obesity, diabetes, cardiovascular and kidney diseases by reg2019